Learn more

PEARL THERAPEUTICS INC

Overview
  • Total Patents
    179
  • GoodIP Patent Rank
    15,055
  • Filing trend
    ⇧ 150.0%
About

PEARL THERAPEUTICS INC has a total of 179 patent applications. It increased the IP activity by 150.0%. Its first patent ever was published in 2010. It filed its patents most often in Australia, United States and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, medical technology and machines are VECTURA LTD, ADVANCED INHALATION RES INC and NEURODERM LTD.

Patent filings per year

Chart showing PEARL THERAPEUTICS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Joshi Vidya B 107
#2 Vehring Reinhard 106
#3 Dwivedi Sarvajna Kumar 102
#4 Smith Adrian Edward 88
#5 Hartman Michael Steven 88
#6 Lechuga-Ballesteros David 50
#7 Dwivedi Sarvajna 22
#8 Reinhard Vehring 19
#9 Sarvajna Kumar Dwivedi 17
#10 Ferriter Matthew 17

Latest patents

Publication Filing date Title
KR20200070284A Drug delivery systems and related methods
CN108136144A Aerosol delivery systems
AU2015201864A1 Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting B2 adrenergic receptor agonists and associated methods and systems
AU2015201221A1 Compositions for respiratory delivery of active agents and associated methods and systems
AU2015201037A1 Respiratory delivery of active agents
AU2014268482A1 Compositions, methods and systems for respiratory delivery of three or more active agents
SG11201507286QA Methods and systems for conditioning of particulate crystalline materials
US2013092160A1 Compositions, methods and propellant-based systems for respiratory delivery of glycopyrrolate and one or more active agents
CN103687483A Compositions, methods & systems for respiratory delivery of two or more active agents
CN105106200A Compositions, methods and systems for respiratory delivery of two or more active agents
MX2011012685A Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting b2 adrenergic receptor agonists and associated methods and systems.